ayview North Dermatology Clinic

Clinical Trials

We are actively recruiting for participation in trials on chronic hand eczema!

– Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

If you are interested in finding out more details about our ongoing studies, please fill out the form at the bottom of this page below or contact us at 416-222-7546 ext. 110 or by email at renne@bnderm.com.

Ongoing studies no longer enrolling:

– Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo

– A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

– A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis

– A Randomized, Double-Blind and Placebo-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older with Moderate to Severe Atopic Dermatitis

– A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (BE BRIGHT)

– A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis (Measure Up 2)

– Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (JADE EXTEND)

– Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis (VALUE)

– Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate2)

– Long-Term Safety and Efficacy of BMS-986165 in Subjects with Psoriasis

– Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis

– A Registry of Patients With Moderate to Severe Plaque Psoriasis (PURE)

security code

All information collected is confidential and handled in accordance with our privacy policy. By filling out this contact form, you are in no way obligated to participate in the trial.

Contact Us

Use the Contact Block below to collect email addresses. Learn more here.

security code